A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Diring, Jessica ^a   Camuzeaux, Barbara ^a   Donzeau, Mariel ^a   Vigneron, Marc ^a   Rosa Calatrava, Manuel ^b   Kedinger, Claude ^a   Chatton, Bruno ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; ACTIVATING TRANSCRIPTION FACTOR 7 4; ACTIVATING TRANSCRIPTION FACTOR 7 FL; DNA 26S; ISOPROTEIN; LEUCINE ZIPPER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEASOME; PROTEOME; UNCLASSIFIED DRUG; ACTIVATING TRANSCRIPTION FACTOR 2; ATF2 PROTEIN, HUMAN; ATF7 PROTEIN, HUMAN; THREONINE;

ACTIVATING TRANSCRIPTION FACTOR 2 GENE; ACTIVATING TRANSCRIPTION FACTOR 7 GENE; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DNA MODIFICATION; DOWN REGULATION; FEMALE; FETUS; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UBIQUITINATION; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CELL STRAIN HCT116; CELL STRAIN HEK293; GENETICS; HELA CELL; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE HOMOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ACTIVATING TRANSCRIPTION FACTOR 2; ACTIVATING TRANSCRIPTION FACTORS; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; CYTOPLASM; HCT116 CELLS; HEK293 CELLS; HELA CELLS; HUMANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE HOMOLOGY, AMINO ACID; THREONINE; TRANSCRIPTIONAL ACTIVATION;

EID: 80051683100     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023351     Document Type: Article

References (82)

1. Hunter T, (2007) The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell 28: 730-738.
2. Hai TW, Liu F, Coukos WJ, Green MR, (1989) Distinguishable promoter elements are involved in transcriptional activation by E1a and cyclic AMP. MolCell Biol 9: 4390-4397.
3. Maekawa T, Sakura H, Kanei-Ishii C, Sudo T, Yoshimura T, et al. (1989) Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain. EMBO J 8: 2023-2028.
4. Nomura N, Zu YL, Maekawa T, Tabata S, Akiyama T, et al. (1993) Isolation and characterization of a novel member of the gene family encoding the cAMP response element-binding protein CRE-BP1. JBiolChem 268: 4259-4266.
5. Gaire M, Chatton B, Kedinger C, (1990) Isolation and characterization of two novel, closely related ATF cDNA clones from HeLa cells. Nucleic Acids Res 18: 3467-3473.
6. De Graeve F, Bahr A, Chatton B, Kedinger C, (2000) A murine ATFa-associated factor with transcriptional repressing activity. Oncogene 19: 1807-1819.
7. Duyndam MC, van Dam H, Smits PH, Verlaan M, van der Eb AJ, et al. (1999) The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A. Oncogene 18: 2311-2321.
8. Hamard PJ, Dalbies-Tran R, Hauss C, Davidson I, Kedinger C, et al. (2005) A functional interaction between ATF7 and TAF12 that is modulated by TAF4. Oncogene 24: 3472-3483.
9. Hong S, Choi HM, Park MJ, Kim YH, Choi YH, et al. (2004) Activation and interaction of ATF2 with the coactivator ASC-2 are responsive for granulocytic differentiation by retinoic acid. J Biol Chem 279: 16996-17003.
10. Bhoumik A, Lopez-Bergami P, Ronai Z, (2007) ATF2 on the double- activating transcription factor and DNA damage response protein. Pigment Cell Res 20: 498-506.
11. Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, et al. (2008) The role of ATF-2 in oncogenesis. Bioessays 30: 314-327.
12. Bhoumik A, Gangi L, Ronai Z, (2004) Inhibition of melanoma growth and metastasis by ATF2-derived peptides. Cancer Res 64: 8222-8230.
13. Bhoumik A, Fichtman B, Derossi C, Breitwieser W, Kluger HM, et al. (2008) Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Proc Natl Acad Sci USA 105: 1674-1679.
14. Maekawa T, Shinagawa T, Sano Y, Sakuma T, Nomura S, et al. (2007) Reduced levels of ATF-2 predispose mice to mammary tumors. Mol Cell Biol 27: 1730-1744.
15. Hirose N, Maekawa T, Shinagawa T, Ishii S, (2009) ATF-2 regulates lipopolysaccharide-induced transcription in macrophage cells. Biochem Biophys Res Commun 385: 72-77.
16. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, et al. (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156-160.
17. Gupta S, Campbell D, Dérijard B, Davis RJ, (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science (New York, NY) 267: 389-393.
18. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ, (1996) MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. MolCell Biol 16 (3): 1247-1255.
19. Ouwens DM, de Ruiter ND, van der Zon GC, Carter AP, Schouten J, et al. (2002) Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. Embo J 21: 3782-3793.
20. Zhu X, Lee HG, Raina AK, Perry G, Smith MA, (2002) The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 11: 270-281.
21. Morton S, Davis RJ, Cohen P, (2004) Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2. FEBS Lett 572: 177-183.
22. De Graeve F, Bahr A, Sabapathy KT, Hauss C, Wagner EF, et al. (1999) Role of the ATFa/JNK2 complex in Jun activation. Oncogene 18: 3491-3500.
23. Camuzeaux B, Diring J, Hamard P-J, Oulad-Abdelghani M, Donzeau M, et al. (2008) p38beta2-mediated phosphorylation and sumoylation of ATF7 are mutually exclusive. Journal of Molecular Biology 384: 980-991.
24. Baan B, van Dam H, van der Zon G, Maassen J, Ouwens D, (2006) The role of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase in insulin-induced Thr69 and Thr71 phosphorylation of activating transcription factor 2. Mol Endocrinol 20: 1786-1795.
25. Baan B, van der Zon G, Maassen J, Ouwens D, (2009) The nuclear appearance of ERK1/2 and p38 determines the sequential induction of ATF2-Thr71 and ATF2-Thr69 phosphorylation by serum in JNK-deficient cells. Molecular and Cellular Endocrinology 311: 94-100.
26. Breitwieser W, Lyons S, Flenniken AM, Ashton G, Bruder G, et al. (2007) Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. Genes Dev 21: 2069-2082.
27. Maekawa T, Bernier F, Sato M, Nomura S, Singh M, et al. (1999) Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome. J Biol Chem 274: 17813-17819.
28. Maekawa T, Kim S, Nakai D, Makino C, Takagi T, et al. (2010) Social isolation stress induces ATF-7 phosphorylation and impairs silencing of the 5-HT 5B receptor gene. EMBO J 29 (1): 196-208.
29. Maniatis T, Tasic B, (2002) Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418: 236-243.
30. Ast G, (2004) How did alternative splicing evolve? Nat Rev Genet 5: 773-782.
31. Birzele F, Csaba G, Zimmer R, (2008) Alternative splicing and protein structure evolution. Nucleic Acids Res 36: 550-558.
32. Tress ML, Martelli PL, Frankish A, Reeves GA, Wesselink JJ, et al. (2007) The implications of alternative splicing in the ENCODE protein complement. Proc Natl Acad Sci USA 104: 5495-5500.
33. Goetz J, Chatton B, Mattei MG, Kedinger C, (1996) Structure and expression of the ATFa gene. J Biol Chem 271: 29589-29598.
34. Chatton B, Bocco JL, Goetz J, Gaire M, Lutz Y, et al. (1994) Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity. Oncogene 9: 375-385.
35. Chatton B, Bocco JL, Gaire M, Hauss C, Reimund B, et al. (1993) Transcriptional activation by the adenovirus larger E1a product is mediated by members of the cellular transcription factor ATF family which can directly associate with E1a. Mol Cell Biol 13: 561-570.
36. Kim SJ, Wagner S, Liu F, O'Reilly MA, Robbins PD, et al. (1992) Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature 358: 331-334.
37. van Dam H, Castellazzi M, (2001) Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 20: 2453-2464.
38. Kardassis D, Papakosta P, Pardali K, Moustakas A, (1999) c-Jun transactivates the promoter of the human p21(WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1. J Biol Chem 274: 29572-29581.
39. Bocco JL, Bahr A, Goetz J, Hauss C, Kallunki T, et al. (1996) In vivo association of ATFa with JNK/SAP kinase activities. Oncogene 12: 1971-1980.
40. Rosa-Calatrava M, Grave L, Puvion-Dutilleul F, Chatton B, Kedinger C, (2001) Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization. J Virol 75: 7131-7141.
41. Rosa-Calatrava M, Puvion-Dutilleul F, Lutz P, Dreyer D, de The H, et al. (2003) Adenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation. EMBO Rep 4: 969-975.
42. Meulenbroek RA, Sargent KL, Lunde J, Jasmin BJ, Parks RJ, (2004) Use of adenovirus protein IX (pIX) to display large polypeptides on the virion-generation of fluorescent virus through the incorporation of pIX-GFP. Mol Ther 9: 617-624.
43. Peterson ML, Bertolino S, Davis F, (2002) An RNA polymerase pause site is associated with the immunoglobulin mus poly(A) site. Mol Cell Biol 22: 5606-5615.
44. Millevoi S, Vagner S, (2010) Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation. Nucleic Acids Res 38: 2757-2774.
45. Chao LC, Jamil A, Kim SJ, Huang L, Martinson HG, (1999) Assembly of the cleavage and polyadenylation apparatus requires about 10 seconds in vivo and is faster for strong than for weak poly(A) sites. Mol Cell Biol 19: 5588-5600.
46. Tusnady GE, Simon I, (2001) The HMMTOP transmembrane topology prediction server. Bioinformatics 17: 849-850.
47. Mesbah K, Camus A, Babinet C, Barra J, (2006) Mutation in the Trapalpha/Ssr1 gene, encoding translocon-associated protein alpha, results in outflow tract morphogenetic defects. Mol Cell Biol 26: 7760-7771.
48. Kara CJ, Liou HC, Ivashkiv LB, Glimcher LH, (1990) A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. MolCell Biol 10: 1347-1357.
49. Georgopoulos K, Morgan BA, Moore DD, (1992) Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer. MolCell Biol 12: 747-757.
50. Bailey J, Phillips RJ, Pollard AJ, Gilmore K, Robson SC, et al. (2002) Characterization and functional analysis of cAMP response element modulator protein and activating transcription factor 2 (ATF2) isoforms in the human myometrium during pregnancy and labor: identification of a novel ATF2 species with potent transactivation properties. J Clin Endocrinol Metab 87: 1717-1728.
51. Buschmann T, Yin Z, Bhoumik A, Ronai Z, (2000) Amino-terminal-derived JNK fragment alters expression and activity of c-Jun, ATF2, and p53 and increases H2O2-induced cell death. J Biol Chem 275: 16590-16596.
52. Livingstone C, Patel G, Jones N, (1995) ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J 14 (8): 1785-1797.
53. van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, et al. (1995) ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J 14: 1798-1811.
54. Bhoumik A, Huang TG, Ivanov V, Gangi L, Qiao RF, et al. (2002) An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 110: 643-650.
55. Bhoumik A, Jones N, Ronai Z, (2004) Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity. Proc Natl Acad Sci U S A 101: 4222-4227.
56. Whitehurst AW, Robinson FL, Moore MS, Cobb MH, (2004) The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions. J Biol Chem 279: 12840-12847.
57. Karlsson M, Mandl M, Keyse SM, (2006) Spatio-temporal regulation of mitogen-activated protein kinase (MAPK) signalling by protein phosphatases. Biochem Soc Trans 34: 842-845.
58. Lu G, Kang YJ, Han J, Herschman HR, Stefani E, et al. (2006) TAB-1 modulates intracellular localization of p38 MAP kinase and downstream signaling. J Biol Chem 281: 6087-6095.
59. Fuchs SY, Tappin I, Ronai Z, (2000) Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation. J Biol Chem 275: 12560-12564.
60. Fuchs SY, Ronai Z, (1999) Ubiquitination and degradation of ATF2 are dimerization dependent. Mol Cell Biol 19: 3289-3298.
61. Lavigne AC, Gangloff YG, Carre L, Mengus G, Birck C, et al. (1999) Synergistic transcriptional activation by TATA-binding protein and hTAFII28 requires specific amino acids of the hTAFII28 histone fold. Mol Cell Biol 19: 5050-5060.
62. Xiao JH, Davidson I, Matthes H, Garnier JM, Chambon P, (1991) Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65: 551-568.
63. Ono K, Han J, (2000) The p38 signal transduction pathway: activation and function. Cell Signal 12: 1-13.
64. Treier M, Staszewski LM, Bohmann D, (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78: 787-798.
65. Friedlander P, Legros Y, Soussi T, Prives C, (1996) Regulation of mutant p53 temperature-sensitive DNA binding. J Biol Chem 271: 25468-25478.
66. Jin S, Shen JN, Wang J, Huang G, Zhou JG, (2007) Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells. Cancer Biol Ther 6: 261-268.
67. Hamard P-J, Dalbies-Tran R, Hauss C, Davidson I, Kedinger C, et al. (2005) A functional interaction between ATF7 and TAF12 that is modulated by TAF4. Oncogene 24: 3472-3483.
68. Kobi D, Steunou A-L, Dembélé D, Legras S, Larue L, et al. (2010) Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene. Pigment Cell Melanoma Res 23 (3): 404-418.
69. Huber AV, Saleh L, Bauer S, Husslein P, Knofler M, (2006) TNFalpha-mediated induction of PAI-1 restricts invasion of HTR-8/SVneo trophoblast cells. Placenta 27: 127-136.
70. Smerc A, Sodja E, Legisa M, (2011) Posttranslational Modification of 6-phosphofructo-1-kinase as an Important Feature of Cancer Metabolism. PLoS ONE 6: e19645.
71. Winter N, Nimzyk R, Bosche C, Meyer A, Bullerdiek J, (2011) Chromatin Immunoprecipitation to Analyze DNA Binding Sites of HMGA2. PLoS ONE 6: e18837.
72. Rosa-Calatrava M, Puvion-Dutilleul F, Lutz P, Dreyer D, de Thé H, et al. (2003) Adenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation. EMBO Rep 4: 969-975.
73. Bailey D, O'Hare P, (2002) Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease. J Gen Virol 83: 2951-2964.
74. Alexaki VI, Javelaud D, Mauviel A, (2008) JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis. Pigment Cell Melanoma Res 21: 429-438.
75. Dutertre S, Sekhri R, Tintignac LA, Onclercq-Delic R, Chatton B, et al. (2002) Dephosphorylation and subcellular compartment change of the mitotic Bloom's syndrome DNA helicase in response to ionizing radiation. J Biol Chem 277: 6280-6286.
76. de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S, (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7: 725-737.
77. Steghens JP, Min KL, Bernengo JC, (1998) Firefly luciferase has two nucleotide binding sites: effect of nucleoside monophosphate and CoA on the light-emission spectra. Biochem J 336 (Pt 1): 109-113.
78. Brou C, Chaudhary S, Davidson I, Lutz Y, Wu J, et al. (1993) Distinct TFIID complexes mediate the effect of different transcriptional activators. EMBO J 12: 489-499.
79. Zimmerman T, Petit Frere C, Satzger M, Raba M, Weisbach M, et al. (2006) Simultaneous metal chelate affinity purification and endotoxin clearance of recombinant antibody fragments. J Immunol Methods 314: 67-73.
80. Lutz P, Rosa-Calatrava M, Kedinger C, (1997) The product of the adenovirus intermediate gene IX is a transcriptional activator. JVirol 71: 5102-5109.
81. Hamard PJ, Boyer-Guittaut M, Camuzeaux B, Dujardin D, Hauss C, et al. (2007) Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity. Nucleic Acids Res 35: 1134-1144.
82. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.